about
Smoking induces long-lasting effects through a monoamine-oxidase epigenetic regulationRisk scoring for the primary prevention of cardiovascular diseaseInterventions for improving modifiable risk factor control in the secondary prevention of strokeRisk scoring for the primary prevention of cardiovascular diseaseRisk scoring for the primary prevention of cardiovascular diseaseAlpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucosePredictive accuracy of the Framingham coronary risk score in British men: prospective cohort studyThe Blood Pressure "Uncertainty Range" - a pragmatic approach to overcome current diagnostic uncertainties (II)Randomized trial evaluating the framing of cardiovascular risk and its impact on blood pressure control [ISRCTN87597585]Risk assessment in the prevention of cardiovascular disease in low-resource settingsChemerin as an independent predictor of cardiovascular event riskCardiovascular riskCerebral ischemic stroke: is gender important?Evaluation of the performance of existing non-laboratory based cardiovascular risk assessment algorithmsCoronary CT and the coronary calcium score, the future of ED risk stratification?Concise review: heart regeneration and the role of cardiac stem cellsEconomics of Team-based Care in Controlling Blood Pressure: A Community Guide Systematic ReviewDoes cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease?Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implicationsHeart to Heart: a computerized decision aid for assessment of coronary heart disease risk and the impact of risk-reduction interventions for primary preventionWill changes in primary care improve health outcomes? Modelling the impact of financial incentives introduced to improve quality of care in the UKAspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trialsAspirin for everyone older than 50? ForEvaluating national guidelines for prevention of cardiovascular disease in primary careCardiovascular risk assessment in patients with retinal vein occlusionThe cost-effectiveness of drug treatments for primary prevention of cardiovascular disease: a modelling studyThe use of cardiovascular risk factor information in practice databases: making the best of patient dataCardioprotective aspirin users and their excess risk of upper gastrointestinal complicationsImpact on hypertension control of a patient-held guideline: a randomised controlled trial.Primary prevention of cardiovascular disease: cost-effectiveness comparisonMultivariate risk assessment and risk score cards in hypertensionA score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trialsPopulation implications of lipid lowering for prevention of coronary heart disease: data from the 1995 Scottish health surveyA laboratory based intervention to improve appropriateness of lipid tests and audit cholesterol lowering in primary careAngiotensin converting enzyme inhibitor and HMG-CoA reductase inhibitor as adjunct treatment for persons with HIV infection: a feasibility randomized trialHealth risks and changes in self-efficacy following community health screening of adults with serious mental illnessesPalm oil taxes and cardiovascular disease mortality in India: economic-epidemiologic modelSeparate prediction of intracerebral hemorrhage and ischemic strokeScreening for future cardiovascular disease using age alone compared with multiple risk factors and ageLoci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
P2860
Q21142700-0B4663C9-3EB8-4745-A36F-89DF69D5DA98Q24186884-566EF424-CD90-4BD8-BF04-AC42CCB552EAQ24194771-DB25A216-C137-4BD9-8BAA-EC1F1B302C14Q24198953-F89C2058-0B72-4DE2-83B8-8249C513F7DDQ24242166-09BBDBAD-C374-4247-B8FB-244795AF45E1Q24244041-213E2839-ABCE-4F60-ABE0-15D11EB1B44BQ24630111-ABE15C36-F5F4-4772-81E1-FB6B831D681DQ24793325-A27600AA-904E-4A5A-8AFB-306C6234601BQ24806491-99BFF9D7-D8AD-42EC-99E8-4E0A14F5BA1BQ26744435-2DC1F9BB-3077-416B-B58B-0DB1E5DD2264Q26752472-A01E8756-E254-40A5-9DC5-9E5EA6DD4F24Q26825634-7E599331-8774-48FA-8D82-96BCBBE6262BQ26863282-27AA80A0-10C1-441E-9DA9-A9CB911CFC53Q26864118-8CC16252-62B1-42DA-A5EE-2A12DDB0DCB4Q27005809-EC8E4B59-7221-49CB-8EB8-67F31ACBD0ABQ27021931-39532EC7-7EE4-4937-BAA3-479AB28D8DEAQ28083249-9F7042B0-CAB5-4673-8FEF-A69C09A34E0BQ28167359-8A02A1F2-8AE4-41EA-B619-D6410294D1EAQ28167649-6BE55742-0863-4786-9561-1D5E5EBDE516Q28167662-F7F8B71F-7E16-41F6-84CC-E2485BE57918Q28168828-77D31679-392A-4E32-BA4B-62970C334DB3Q28175861-A642EAEF-E25B-4394-A4B0-DD2269C68AD5Q28180812-6F65868E-2483-42E3-9F26-3292AFDD4C1FQ28191895-E1EA56E2-5B5A-4EF6-88C7-2705114689FAQ28193280-4CD38299-33E8-4B1C-B1A6-94401CDB4966Q28199830-188381A8-D6F5-48BB-8FF0-C8C85C29F0A3Q28199922-81CDE9ED-4591-49B2-BDEF-C1FDD5A857A4Q28200511-05070C3A-265A-456D-8885-0FC7915E71ECQ28211304-3B0D79B9-4D77-4077-8BB6-63F147001600Q28217877-40BAFF3E-A807-44C0-BBBE-AA9CBDA1684DQ28219606-83A9B5D5-C411-46C5-9613-DD400AE464DCQ28343811-A9F3EC57-609F-44A3-8F9C-4D3B4E108DD9Q28346455-1B511BF3-1BEB-41F9-806C-605455B3A846Q28364777-A8B7F838-8676-4552-8672-C57A8A6CB2CDQ28484460-5875C5AE-C496-47C6-8851-2BD7512A8242Q28546182-5CE5198F-A7C4-4CD5-8C10-92BF0B085AA3Q28603638-38897DE3-14A8-4987-BA30-9834D7EC986FQ28659201-A1333A6C-E353-4489-8AE6-77ABEE6DDA5FQ28740466-733E3A74-13F9-4EE7-A604-00EB79A07248Q29614946-DF03D17F-D093-4ABD-96D9-4DEDC7C518D0
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Cardiovascular disease risk profiles.
@en
Cardiovascular disease risk profiles.
@nl
type
label
Cardiovascular disease risk profiles.
@en
Cardiovascular disease risk profiles.
@nl
prefLabel
Cardiovascular disease risk profiles.
@en
Cardiovascular disease risk profiles.
@nl
P2093
P1476
Cardiovascular disease risk profiles.
@en
P2093
K M Anderson
P W Wilson
W B Kannel
P304
P356
10.1016/0002-8703(91)90861-B
P407
P433
P577
1991-01-01T00:00:00Z